Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Following Market Engagement and a formal procurement process, NHS Midlands and Lancashire Commissioning Support Procurement Unit is issuing this Intention to Award Contract Notice on behalf of NHS Herefordshire and Worcestershire Integrated Care Board (ICB) to inform the market that it intends to award two contracts for early intervention and preventative emotional wellbeing and mental health services for Children and Young People (CYP) age 0 to 25 years, across the counties of Herefordshire and Worcestershire.
These services are classed as Health Care services under The Health Care Services (Provider Selection Regime) Regulations 2023 (PSR). The ICB has adopted a Competitive Process in accordance with Regulations 6(7) and 11 of the PSR Regulations.
Under the PSR Regulations, the ICB was required to assess bids based on basic Selection Criteria, Five Key Criteria (as defined in Regulation 5 of the PSR), and any other elements relevant to contract award. The ICB applied the Crown Commercial Services Selection Questionnaire for the basic Selection Criteria.
Following the assessment, the ICB is intending to award contracts for two lots for the above services, i.e., Lot 1 - Herefordshire, Lot 2 - Worcestershire, for a period of 3 years with the option to extend for up to another 2 years at its discretion.
Bidding organisations were able to submit bids for either lot, or for both lots.
The contracts for both lots will mobilise from the 1st April 2025.
The total estimated lifetime value of the contract is £7,127,600 for the 3 year contract plus the optional extension period of 2 years; this is split to £1,781,900 for Lot 1 (Herefordshire), and £5,345,700 for Lot 2 (Worcestershire).
The service is expected to be offered with flexibility to meet local need; some evening and weekend provision will also be required.
The indicative proposed minimum activity levels were 1647 per year for Lot 1 (Herefordshire), and 5022 per year for Lot 2 (Worcestershire).
This notice has been issued subject to the Provider Selection Regime (PSR) regulations 2023 for the Procurement of Healthcare Services.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Accord-UK Ltd | 00079585 | - | - | - |
| AGB Pharma | 11316999 | - | - | - |
| Aguettant Ltd | 04966231 | - | - | - |
| Alissa Healthcare Research Limited | 05848896 | - | - | - |
| Amarox Limited | 10997632 | - | - | - |
| AOP Orphan Ltd | 08082765 | - | - | - |
| Arcadia Pharma Ltd T/A Arcadia Medical | - | - | - | - |
| Ascend Laboratories UK Ltd | 09164483 | - | - | - |
| Aspen Pharmacare UK Limited | 11411661 | - | - | - |
| Aspire Pharma Limited | 09306251 | - | - | - |
| Aventis Pharma ltd t/a Sanofi | 01535640 | - | - | DONOR£101K across 3 donations To: Pauline Latham MP, Derek Thomas, Labour Party |
| Baxter Healthcare Ltd | 00461365 | - | - | LOBBYIST WA Communications Ltd (3 quarters) |
| B. Braun Medical Limited | 02296559 | - | - | - |
| Beaumont Pharma Ltd | 12518247 | - | - | - |
| Biocon | - | - | - | - |
| Bowmed Ibisqus Limited | 06204088 | - | - | - |
| Brown and Burk UK Ltd | - | - | - | - |
| Celix Pharma Ltd. | 12474195 | - | - | - |
| Chiesi Limited | 02140985 | - | - | LOBBYIST Ovid Consulting Ltd (7 quarters) Hill & Knowlton Limited (4 quarters) Portland PR Limited (2 quarters) |
| Cipla | - | - | - | - |
| Colonis Pharma Ltd | 05486832 | - | - | - |
| Consilient Health Ltd | 05427634 | - | - | - |
| Crescent Pharma Ltd | 04750933 | - | - | - |
| CST Pharma Limited | 04212740 | - | - | - |
| Day Lewis Medical Ltd | 01904504 | - | - | - |
| Desitin Pharma Ltd | 07914851 | - | - | - |
| Dr.Reddy's Laboratories (UK) Limited | 01729064 | - | - | - |
| Drugsrus Ltd | 04916914 | - | - | - |
| ennogen healthcare ltd | 07809880 | - | - | - |
| Eramol (UK) Ltd | 08681617 | - | - | - |
| Essential Pharma | 07514667 | - | - | - |
| Esteve Pharmaceuticals Ltd | 03393686 | - | - | - |
| Farmak Pharmaceuticals | 15398948 | - | - | - |
| Ferring Pharmaceuticals Ltd | 01198007 | - | - | DONOR£1.44M across 11 donations To: Liberal Democrats |
| Flexipharm Austrading Limited | 11368401 | - | - | - |
| FLYNN PHARMA LTD | FC018156 | - | - | - |
| Focus Pharmaceuticals Ltd | 04522142 | - | - | - |
| Fontus Health Ltd | 08072503 | - | - | - |
| Fresenius Kabi Limited | 02182135 | - | - | - |
| Galen Limited | NI056542 | - | - | LOBBYIST MHP Communications (1 quarter) |
| Galvany Pharma Ltd | 13977261 | - | - | - |
| GENNISIUM PHARMA | - | - | - | - |
| GlaxoSmithKline UK Limited | 04310159 | - | - | LOBBYIST Hill & Knowlton Limited (4 quarters) Global Counsel Ltd (1 quarter) |
| Glenmark Pharmaceuticals Europe Limited | 05040260 | - | - | - |
| G.L. Pharma UK Limited | 11829209 | - | - | - |
| hameln pharma ltd | 01034697 | - | - | - |
| Hikma Pharmaceuticals | - | - | - | - |
| Immedica Pharma AB | - | - | - | - |
| JCSH Pharma Ltd | 10090970 | - | - | - |
| Kent Pharma Ltd | - | - | - | - |
| Lipomed AG | - | - | - | - |
| LogixX Pharma Ltd | 07209211 | - | - | - |
| Lucane Pharma | - | - | - | - |
| Lundbeck Limited | 01040798 | - | - | - |
| Macleods Pharma UK Limited | 06455382 | - | - | - |
| Macure Pharma ApS | - | - | - | - |
| Manx Healthcare Ltd | 02904497 | - | - | - |
| Martindale Pharma | - | - | - | - |
| medac Pharma LLP | OC415849 | - | - | - |
| Medreich PLC | 03122988 | - | - | - |
| Merck Sharpe and Dohme (UK) Limited | - | - | - | - |
| Mercury Pharmaceuticals Limited | 02619880 | - | - | - |
| Milpharm Ltd/aurobinbdo Primary | - | - | - | - |
| Morningside Pharmaeuticals | - | - | - | - |
| MSN Laboratories Europe Limited | 10185013 | - | - | - |
| Mylan | 05460854 | - | - | - |
| Necessity Supplies Limited | 02010112 | - | - | - |
| Neon Healthcare Ltd | 06844351 | - | - | - |
| Neuraxpharm UK Ltd | 10918621 | - | - | - |
| Novumgen Limited | 13510476 | - | - | - |
| ONSIDE Independent Advocacy | Charity Commission: 1102022 Companies House: 04923990 | ~£1,781,900 estimated from lot values | 1 lot Lot 1 - Herefordshire | - |
| Otsuka Pharmaceuticals UK Limited | 03615891 | - | - | - |
| Panpharma UK Limited | 09519853 | - | - | - |
| Pari Medical UK | 02937493 | - | - | - |
| Perennial Pharma Ltd | 11826246 | - | - | - |
| Pfizer Ltd | 00526209 | - | - | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Ovid Consulting Ltd (3 quarters) Hanover Communications International Limited (3 quarters) Incisive Health Ltd (1 quarter) MHP Communications (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Phoenix Lab | - | - | - | - |
| Pierre Fabre Ltd | 00986738 | - | - | - |
| Piramal Critical care Limited | 05160306 | - | - | - |
| Recordati Pharmaceuticals Ltd | 05421174 | - | - | - |
| Reig Jofre UK limited | 09301085 | - | - | - |
| Roche Products Ltd | 00100674 | - | - | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| Roma Pharmaceuticals Limited | 10217518 | - | - | - |
| RPH Pharmaceuticals AB | - | - | - | - |
| Sandoz Ltd | 01547204 | - | - | - |
| Scope Ophthalmics | 07883194 | - | - | - |
| Seacross Pharmaceuticals Ltd | 07650983 | - | - | - |
| Selective Supplies Ltd. | 03794482 | - | - | - |
| Sobi (Swedish Orphan Biovitrum Ltd) | - | - | - | - |
| Stirling Anglian Pharmaceuticals Ltd | SC453258 | - | - | - |
| Strides Pharma Uk LTD | 02882063 | - | - | - |
| Sun Pharma UK Ltd | 02992795 | - | - | - |
| SVP Pharma Ltd | 13849821 | - | - | - |
| Synchrony | - | - | - | - |
| Teva UK Limited | 00302461 | - | - | - |
| Thea Pharmaceuticals Limited | 06505496 | - | - | - |
| Thornton and Ross Ltd | 00185947 | - | - | - |
| Tillomed Laboratories ltd | 02544103 | - | - | - |
| Torbay Pharmaceuticals | 14955659 | - | - | - |
| Torrent Pharma UK Ltd | 07249393 | - | - | - |
| Vantage Pharmaceuticals Ltd | 13095005 | - | - | - |
| Waymade PLC | - | - | - | - |
| Wockhardt UK Limited | 05835570 | - | - | - |
| Zentiva Pharma UK Ltd | 02158996 | - | - | - |
This procurement was divided into 2 lots, each awarded separately. 5 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Lot 1 - Herefordshire 1,800 days (≈4.9 yrs) | £1,781,900 £7,127,600 initial term | 5 | ONSIDE Independent Advocacy | active |
| Lot 2 Lot 2 - Worcestershire 1,800 days (≈4.9 yrs) | £5,345,700 | - | - | cancelled |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £1,778,125,071 in 17,567 payments (over £25k) from NHS Supply Chain (DHSC-funded), UK Health Security Agency, The Christie NHS Foundation Trust, Department of Health and Social Care, Guy's and St Thomas' NHS FT and 20 more public bodies (2010-04-01 to 2026-03-31).
Changes the buyer published to this notice after it first appeared.
This is a Provider Selection Regime (PSR) confirmation of contract award notice This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the voidance of doubt, the Public Contracts Regulations do not apply to this award.
This contract has now been formally awarded using the Competitive Process.
There were no declared nor potential conflicts of interest of any individuals making the decision.
Date of contract award: 24th December 2024.
Dates between which the services are intended to be provided: 1st April 2025 to 31st March 2028 (or until 31st March 2030 subject to an optional extension of 2 years).
Lifetime value of the contract: £7,127,600 for the 3 year contract including the optional extension period of 2 years; this is split to £1,781,900 for Lot 1 (Herefordshire), and £5,345,700 for Lot 2 (Worcestershire).
Published by the buyer on this notice. Check the original notice — details change and are not updated here.